Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4103/ijo.IJO_310_21 http://scihub22266oqcxt.onion/10.4103/ijo.IJO_310_21 34011742!8302276!34011742     free     free     free       Indian+J+Ophthalmol 2021 ; 69 (6): 1563-1568 Nephropedia Template TP {{tp|p=34011742|t=2021. Rise of the phoenix: Mucormycosis in COVID-19 times |pdf=|usr=}}{{34011742}} gab.com Text Rise of the phoenix: Mucormycosis in COVID-19 times JO: Indian J Ophthalmol http://www.kidney.de/pget.php?&tw=1&pmid=34011742 #FOAvip PURPOSE: Rhino-orbital mucormycosis in times of ongoing COVID-19 pandemic. AIMS: The aim of the study was to document cases of rhino-orbital mucormycosis seen at our Regional Institute of Ophthalmology during COVID-19 (coronavirus disease 2019) times. METHODS: The study is a retrospective, institutional cohort, interventional study. It was carried out at our Regional Institute of Ophthalmology from September 2020 to mid-March 2021. All patients of biopsy-proven mucormycosis were enrolled in the study. The patients were subjected to complete history taking, ophthalmological examination, and imaging studies. The patients were treated via a multidisciplinary approach with intravenous liposomal amphotericin B and debridement of local necrotic tissue. Exenteration was done when indicated. A minimum 75-day follow-up period was accorded to all study patients. Statistical analysis was done using Chi-square test. A P value </=0.05 was taken as significant. RESULTS: Thirty-one patients were seen, with a mean age of 56.3 years. The major risk factors included uncontrolled diabetes (96.7%) and COVID-19 positivity (61.2%), with concomitant steroid use in 61.2% patients. The most common presentation was diminution of vision (<6/60 in 80.64% patients) and ophthalmoplegia (77.4%). The most common imaging findings were orbital cellulitis (61.29%) and pansinusitis (77.4%). Intravenous liposomal amphotericin B was given to all patients for an average 18.93 days. Exenteration was required in (n = 4) 12.9% of cases. Twenty-eight patients recovered and were alive on follow-up. Mortality was seen in three patients. The presence of cerebral involvement and a HbA1c value of >/=8 were found to be significant in the prediction of survival of patients with mucormycosis. CONCLUSION: We present the largest institutional cohort of rhino-orbital mucormycosis patients during the ongoing COVID-19 pandemic era from our unique perspective. Twit Text FOAVip Rise of the phoenix: Mucormycosis in COVID-19 times ????Indian J Ophthalmol http://www.kidney.de/pget.php?&tw=1&pmid=34011742 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34011742 #FOAvip English Wikipedia <ref>{{Cite pmid|34011742}}</ref> Rise of the phoenix: Mucormycosis in COVID-19 times #MMPMID34011742 Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD Indian J Ophthalmol 2021[Jun]; 69 (6): 1563-1568 PMID34011742show ga PURPOSE: Rhino-orbital mucormycosis in times of ongoing COVID-19 pandemic. AIMS: The aim of the study was to document cases of rhino-orbital mucormycosis seen at our Regional Institute of Ophthalmology during COVID-19 (coronavirus disease 2019) times. METHODS: The study is a retrospective, institutional cohort, interventional study. It was carried out at our Regional Institute of Ophthalmology from September 2020 to mid-March 2021. All patients of biopsy-proven mucormycosis were enrolled in the study. The patients were subjected to complete history taking, ophthalmological examination, and imaging studies. The patients were treated via a multidisciplinary approach with intravenous liposomal amphotericin B and debridement of local necrotic tissue. Exenteration was done when indicated. A minimum 75-day follow-up period was accorded to all study patients. Statistical analysis was done using Chi-square test. A P value /=8 were found to be significant in the prediction of survival of patients with mucormycosis. CONCLUSION: We present the largest institutional cohort of rhino-orbital mucormycosis patients during the ongoing COVID-19 pandemic era from our unique perspective. |*COVID-19[MESH] |*Eye Infections, Fungal/diagnosis/drug therapy/epidemiology[MESH] |*Mucormycosis/diagnosis/epidemiology/therapy[MESH] |*Orbital Diseases/drug therapy[MESH] |Antifungal Agents/therapeutic use[MESH] |Debridement[MESH] |Humans[MESH] |Middle Aged[MESH] |Pandemics[MESH] |Retrospective Studies[MESH]Rise of the phoenix: Mucormycosis in COVID-19 times (epmc).pdf DeepDyve Pubget Overpricing